Farallon Capital Management LLC Boston Scientific Corp Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Farallon Capital Management LLC holds 5,425,657 shares of BSX stock, worth $483 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares

5,425,657

Previous 4,109,157 32.04%

Holding current value

$483 Million

Previous $316 Million 43.68%

% of portfolio

2.29%

Previous 1.53%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $96.1 Million - $111 Million	1,316,500 Added 32.04%	5,425,657 $455 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $32.8 Million - $37.9 Million	-487,500 Reduced 10.61%	4,109,157 $316 Million
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $70.5 Million - $84 Million	-1,223,600 Reduced 21.02%	4,596,657 $315 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $283 Million - $336 Million	5,820,257 New	5,820,257 $336 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $253 Million - $276 Million	5,039,257 New	5,039,257 $266 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $132 Million - $145 Million	-2,660,000 Reduced 34.52%	5,045,257 $273 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $70.1 Million - $77.8 Million	-1,555,000 Reduced 16.79%	7,705,257 $385 Million
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $114 Million - $137 Million	-2,891,000 Reduced 23.79%	9,260,257 $429 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $106 Million - $318 Million	-2,896,000 Reduced 19.25%	12,151,257 $471 Million
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $24.4 Million - $32.6 Million	-693,000 Reduced 4.4%	15,047,257 $561 Million
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $43.9 Million - $48.5 Million	-1,074,324 Reduced 6.39%	15,740,257 $697 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $107 Million - $126 Million	2,812,000 Added 20.08%	16,814,581 $714 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $53 Million - $59 Million	1,285,962 Added 10.11%	14,002,581 $608 Million
Q2 2021 Aug 13, 2021	SELL	$38.58 - $44.24 $4.1 Million - $4.7 Million	-106,250 Reduced 0.83%	12,716,619 $544 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $14.7 Million - $16.5 Million	-415,450 Reduced 3.14%	12,822,869 $496 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $165 Million - $208 Million	4,962,400 Added 59.96%	13,238,319 $476 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $285 Million - $349 Million	8,275,919 New	8,275,919 $316 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $127B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Boston Scientific Corp Transaction History